Cargando…

Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma

BACKGROUND: Chondrosarcoma (CS) most commonly involves the pelvis. This study aimed to analyze differences in clinical characteristics and prognostic factors between primary and secondary conventional pelvic CS, and provide reference for clinical diagnosis and treatment. METHODS: Eighty patients (54...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Jie, Guo, Wei, Yang, Rongli, Tang, Xiaodong, Liang, Haijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607637/
https://www.ncbi.nlm.nih.gov/pubmed/33138794
http://dx.doi.org/10.1186/s12885-020-07530-9
_version_ 1783604680400568320
author Zang, Jie
Guo, Wei
Yang, Rongli
Tang, Xiaodong
Liang, Haijie
author_facet Zang, Jie
Guo, Wei
Yang, Rongli
Tang, Xiaodong
Liang, Haijie
author_sort Zang, Jie
collection PubMed
description BACKGROUND: Chondrosarcoma (CS) most commonly involves the pelvis. This study aimed to analyze differences in clinical characteristics and prognostic factors between primary and secondary conventional pelvic CS, and provide reference for clinical diagnosis and treatment. METHODS: Eighty patients (54 primary cases and 26 secondary cases) with pelvic CS were included in this retrospective study. The tumor site, Enneking stage, soft tissue mass, margin, initial tumor grade, incidence of local recurrence and distant metastasis were evaluated. Kaplan-Meier method was used to calculate the overall survival rate. X(2) test and log-rank test were used for univariate analysis, and Cox test was used in multivariate analysis. RESULTS: The average age of patients with secondary CS was significantly younger than that of patients with primary CS (P < 0.001). The soft tissue mass of patients with secondary CS was significantly larger than that of patients with primary CS (P = 0.002). There was a significant difference in initial tumor pathologic grade between the two groups (P = 0.002). No statistically significant difference was observed in the local recurrence rate between the two groups. The median recurrence time of patients with primary CS after the first treatment was significantly shorter than that of patients with secondary CS (P < 0.001). The overall survival rate of patients with secondary CS was much higher than that of patients with primary CS (P = 0.003). Cox regression analysis showed that the initial tumor grade was an independent factor in the overall survival rate of patients with CS. CONCLUSION: There were significant differences in age, soft tissue mass, initial tumor grade, and overall survival rate between the two groups. The overall survival rate of pelvic CS was related to the initial tumor grade of CS.
format Online
Article
Text
id pubmed-7607637
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76076372020-11-03 Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma Zang, Jie Guo, Wei Yang, Rongli Tang, Xiaodong Liang, Haijie BMC Cancer Research Article BACKGROUND: Chondrosarcoma (CS) most commonly involves the pelvis. This study aimed to analyze differences in clinical characteristics and prognostic factors between primary and secondary conventional pelvic CS, and provide reference for clinical diagnosis and treatment. METHODS: Eighty patients (54 primary cases and 26 secondary cases) with pelvic CS were included in this retrospective study. The tumor site, Enneking stage, soft tissue mass, margin, initial tumor grade, incidence of local recurrence and distant metastasis were evaluated. Kaplan-Meier method was used to calculate the overall survival rate. X(2) test and log-rank test were used for univariate analysis, and Cox test was used in multivariate analysis. RESULTS: The average age of patients with secondary CS was significantly younger than that of patients with primary CS (P < 0.001). The soft tissue mass of patients with secondary CS was significantly larger than that of patients with primary CS (P = 0.002). There was a significant difference in initial tumor pathologic grade between the two groups (P = 0.002). No statistically significant difference was observed in the local recurrence rate between the two groups. The median recurrence time of patients with primary CS after the first treatment was significantly shorter than that of patients with secondary CS (P < 0.001). The overall survival rate of patients with secondary CS was much higher than that of patients with primary CS (P = 0.003). Cox regression analysis showed that the initial tumor grade was an independent factor in the overall survival rate of patients with CS. CONCLUSION: There were significant differences in age, soft tissue mass, initial tumor grade, and overall survival rate between the two groups. The overall survival rate of pelvic CS was related to the initial tumor grade of CS. BioMed Central 2020-11-02 /pmc/articles/PMC7607637/ /pubmed/33138794 http://dx.doi.org/10.1186/s12885-020-07530-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zang, Jie
Guo, Wei
Yang, Rongli
Tang, Xiaodong
Liang, Haijie
Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title_full Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title_fullStr Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title_full_unstemmed Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title_short Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
title_sort differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607637/
https://www.ncbi.nlm.nih.gov/pubmed/33138794
http://dx.doi.org/10.1186/s12885-020-07530-9
work_keys_str_mv AT zangjie differencesinclinicalcharacteristicsandtumorprognosisbetweenprimaryandsecondaryconventionalpelvicchondrosarcoma
AT guowei differencesinclinicalcharacteristicsandtumorprognosisbetweenprimaryandsecondaryconventionalpelvicchondrosarcoma
AT yangrongli differencesinclinicalcharacteristicsandtumorprognosisbetweenprimaryandsecondaryconventionalpelvicchondrosarcoma
AT tangxiaodong differencesinclinicalcharacteristicsandtumorprognosisbetweenprimaryandsecondaryconventionalpelvicchondrosarcoma
AT lianghaijie differencesinclinicalcharacteristicsandtumorprognosisbetweenprimaryandsecondaryconventionalpelvicchondrosarcoma